The ruling comes after NYU Langone sued its competitor, Northwell Health, last year over claims that the hospital system had copied NYU’s signature purple brand colors in its own advertising campaigns.
Toxic gas that sterilizes medical devices prompts safety rule update
There are about 90 sterilizing plants in the U.S. that use ethylene oxide, and for decades companies used the chemical to sterilize medical products without drawing much attention.
Patients see first savings from Biden’s drug price push, as pharma lines up its lawyers
A restructuring of the Medicare drug benefit has wiped out big drug price bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.
FDA repeatedly rejected safety claims made by Philips after the CPAP recall but waited to alert the public, emails show
As Philips reassured patients that millions of recalled machines were safe, internal emails show federal regulators privately told the company its testing didn’t account for the impact of long-term harm from tainted devices.
FDA’s plan to ban hair relaxer chemical called too little, too late
In April the Food and Drug Administration is tentatively scheduled to unveil a proposal to consider banning the chemical in hair-straightening products.
Under Ken Paxton, Texas’ elite civil Medicaid fraud unit is falling apart
After the chief of the attorney general’s Civil Medicaid Fraud Division was forced out last year, two-thirds of attorneys have quit the unit, leaving it at its smallest size since Paxton took office.
Amid recall crisis, Philips agrees to stop selling sleep apnea machines in the United States
The breathing machine manufacturer has faced relentless criticism over its handling of the 2021 recall of millions of devices. Philips must meet the requirements outlined in an agreement with the Justice Department before it can resume sales.
Medicare certifies hospices in California despite state ban on new licenses
The agency has rolled out sweeping changes to target end-of-life care providers that were billing for unneeded services, but some fraud hot spots continue to evade scrutiny.
Why the FDA wants to add boxed warnings to all six CAR-T drugs
The class-wide warning follows an investigation the FDA launched last fall around the risk of T-cell malignancy associated with autologous CAR-T therapies.
Federal lawmakers take first steps toward oversight of $50 billion in opioid settlements
This month, Rep. Marcy Kaptur (D-Ohio) and Rep. Ashley Hinson (R-Iowa) introduced legislation that would write into law approved uses for the funds so they reach people most affected by the crisis.